A systematic review of research on strategies for the management of antipsychotic-induced sexual dysfunction: high-level evidence is needed.
Berner
Michael M
MM
Hagen
Matthias
M
Kriston
Levente
L
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011687:Purines; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012106:Research / Q000706:statistics & numerical data; D012107:Research Design; D012559:Schizophrenia / Q000188:drug therapy; D012642:Selegiline / Q000627:therapeutic use; D020018:Sexual Dysfunctions, Psychological / Q000139:chemically induced* / Q000188:drug therapy*; D000068677:Sildenafil Citrate; D013450:Sulfones; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D008996:Monoamine Oxidase Inhibitors; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D012642:Selegiline; D000068677:Sildenafil Citrate